abstract |
The present invention describes compound of formula 1) (see formula 1) which are novel antagonists for melanin concentrating hormone (MCH), as well as methods for preparing said compounds; In another embodiment, the invention describes pharmaceutical compositions comprising said MCH antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders, such as hyperphagia, and diabetes. |